Apogee Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $109k | 2.7k | 39.73 |
| 2025-06-30 | $142k | 3.3k | 43.43 |
| 2025-03-31 | $143k | 3.8k | 37.36 |
| 2024-12-31 | $174k | 3.8k | 45.30 |
| 2024-09-30 | $226k | 3.8k | 58.74 |
| 2024-06-30 | $139k | 3.5k | 39.35 |
| 2024-03-31 | $274k | 4.1k | 66.45 |
| 2023-12-31 | $55k | 2.0k | 27.94 |
| 2023-09-30 | $42k | 2.0k | 21.30 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors